Post-approval studies (Phase 4)Study completedNCT00430924What this trial is testingInhibition of Aldosterone in Patients With Chronic Renal DiseaseWho this might be right forKidney Failure, Chronic Lene Boesby 42
Not applicableStudy completedNCT04503070What this trial is testingMotion Capture: Baseball SwingWho this might be right forElbow Force The Methodist Hospital Research Institute 16
Testing effectiveness (Phase 2)Study completedNCT00005859What this trial is testingTipifarnib in Treating Patients With Recurrent or Progressive Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 136
Not applicableUnknownNCT03800082What this trial is testingDevelopment and Usability Testing of a Progressive WebApp for Women With Heart DiseaseWho this might be right forPainCardiac IschemiaWomen+1 more University of Toronto 98
Testing effectiveness (Phase 2)Ended earlyNCT00106262What this trial is testingStudy of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal CancerWho this might be right forCervical Cancer Women and Infants Hospital of Rhode Island 38
Early research (Phase 1)Looking for participantsNCT05400603What this trial is testingAllogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed OsteosarcomaWho this might be right forNeuroblastomaRefractory NeuroblastomaRelapsed Neuroblastoma+2 more Emory University 24
Testing effectiveness (Phase 2)Ended earlyNCT00773383What this trial is testingThe Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy.Who this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 35
Very early researchLooking for participantsNCT04634994What this trial is testingAssessment of Synaptic Density in MSWho this might be right forMultiple Sclerosis Brigham and Women's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04211740What this trial is testingPhase II Clinical Trial of OCH-NCNP1Who this might be right forMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive National Center of Neurology and Psychiatry, Japan 30
Not applicableUnknownNCT06404710What this trial is testingProgressive Muscle Relaxation Exercise Applied After Heart SurgeryWho this might be right forthe Participant Wishes to Leave the Study Saglik Bilimleri Universitesi 57
Not applicableStudy completedNCT00465790What this trial is testingResearch of Biomarkers in Parkinson DiseaseWho this might be right forParkinson DiseaseMultiple System AtrophyProgressive Supranuclear Palsy+3 more Institut National de la Santé Et de la Recherche Médicale, France 219
Post-approval studies (Phase 4)Study completedNCT01525550What this trial is testingThe Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine TumorsWho this might be right forWell-differentiated Pancreatic Neuroendocrine Tumor Pfizer 106
Not applicableNot Yet RecruitingNCT07173010What this trial is testingPediatric Arthropathy Beyond Inflammation: Clinical Spectrum and Diagnostic Approach at Assiut University Children HospitalWho this might be right forMucopolysaccharidosesProgressive Pseudorheumatoid DysplasiaFarber Disease+3 more Assiut University 35
Testing effectiveness (Phase 2)Study completedNCT00045110What this trial is testingErlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive MeningiomaWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+6 more National Cancer Institute (NCI) 136
Not applicableNo Longer AvailableNCT02142218What this trial is testingExpanded Access Program With Nivolumab to Treat MelanomaWho this might be right forStage III (Unresectable) or Stage IV Advanced Melanoma Bristol-Myers Squibb
Testing effectiveness (Phase 2)Ended earlyNCT07166367What this trial is testingPhase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast CancerWho this might be right forHER2-positive Breast Cancer National Cancer Centre, Singapore 3
Not applicableEnded earlyNCT04063228What this trial is testingHigh Level Mobility Training in Ambulatory Patients With Acquired Non-progressive Central Neurological InjuryWho this might be right forNeurological Injury NYU Langone Health 28
Not applicableStudy completedNCT02458612What this trial is testingEffects of Mirror Therapy Combined With Progressive Strength Training in Unilateral Spastic Cerebral PalsyWho this might be right forSpastic Hemiplegic Cerebral Palsy Hacettepe University 30
Not applicableLooking for participantsNCT05121012What this trial is testingSynaptic Loss in Multiple System AtrophyWho this might be right forMultiple System AtrophyProgressive Supranuclear Palsy (PSP) University of Exeter 36
Early research (Phase 1)Study completedNCT01231919What this trial is testingMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more National Cancer Institute (NCI) 45